Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Montana Wildhack who wrote (8167)	12/5/2001 8:14:52 PM
From: Cal Gary	Read Replies (2) \| Respond to of 14101

Boy, is Joe going to be choked. Fungoff instead of FDA bundled with the news. <g> BTW, Mrs Krupa mentioned that Joe cannot come to the computer right now, something to do with gaining 25lbs over night. <ggg> NICE to see they got $2.5mm. Should alleviate the cash crunch. I calculated the shares went for $3.69. Plus. A bit more than 2 years have gone by since DMX last mentioned onychomycosis in an NR. In my most simplistic mind, Fungoff clinicals should not take excessive time to complete, but you never know. I guess it depends on the end point. Either the formulation kills fungus or when fungi-toe nail grows out. Plus. "...despite some regulatory delays in PENNSAID approval," said Rebecca Keeler" Psst, this is a hint. Negative. ""We are very pleased to have extended our agreement with Acqua Wellington for an additional few months, through May, 2002," Could be taken as a negative. Any other financing vehicles? When does revenues take off? Overall, a neutral NR. May not help our stock price. Let's see how the three amigos act on this news. That'll determine the short term direction. Look, its almost christmas! Peace and goodwill to all men!